Intravenous use of buprenorphine tablets associated with rhabdomyolysis and compressive sciatic neuropathy.
Raymond C S
RC
Seet
Erle C H
EC
Lim
D000328:Adult; D002047:Buprenorphine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D009220:Myositis / Q000139:chemically induced* / Q000175:diagnosis; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000175:diagnosis; D020426:Sciatic Neuropathy / Q000139:chemically induced* / Q000175:diagnosis; D015819:Substance Abuse, Intravenous; D013607:Tablets
D009292:Narcotic Antagonists; D013607:Tablets; D002047:Buprenorphine